Table 2.

Organ-specific irAEs and the clinical characteristics

Patients, n (%)Months since therapy initiation, median (range)a
Colitis (total)28 (19)1.9 (0.4–4.7)
Sarcoid-like lymphadenopathy8b (5)3.2 (0.2–9.1)
Pneumonitis8c (5)2.3 (1.1 – 8.3)
Hepatitis3 (2)1.4 (0.3–2.7)
Thyroiditis2 (1)4.3 (4.0–4.7)
Pancreatitis1 (0.6)3.8 (3.8)

  • ↵aMedian and range represent those among the patients who had the events.

  • ↵bIncludes 1 patient who also had colitis.

  • ↵cIncludes 3 patients who also had colitis.